| Primary |
| Gastrooesophageal Reflux Disease |
40.7% |
| Hypertension |
13.0% |
| Hypothyroidism |
5.6% |
| Abdominal Pain Upper |
3.7% |
| Gastritis |
3.7% |
| Gastritis Erosive |
3.7% |
| Oesophagitis |
3.7% |
| Peptic Ulcer |
3.7% |
| Ulcer |
3.7% |
| Antacid Therapy |
1.9% |
| Convulsion |
1.9% |
| Erosive Duodenitis |
1.9% |
| Erosive Oesophagitis |
1.9% |
| Fungal Infection |
1.9% |
| Gastric Disorder |
1.9% |
| Gastric Ph Decreased |
1.9% |
| Gastrooesophagitis |
1.9% |
| Hypercholesterolaemia |
1.9% |
| Migraine |
1.9% |
|
| Somnolence |
11.4% |
| Panic Disorder |
8.6% |
| Thrombocytopenia |
8.6% |
| Dyspnoea |
5.7% |
| Pruritus |
5.7% |
| Rash Generalised |
5.7% |
| Urticaria |
5.7% |
| Vision Blurred |
5.7% |
| Visual Impairment |
5.7% |
| Vomiting |
5.7% |
| Weight Decreased |
5.7% |
| Abnormal Dreams |
2.9% |
| Acute Febrile Neutrophilic Dermatosis |
2.9% |
| Arrhythmia |
2.9% |
| Chest Discomfort |
2.9% |
| Feeling Hot |
2.9% |
| Haemorrhage |
2.9% |
| Hepatic Neoplasm |
2.9% |
| Hiatus Hernia |
2.9% |
| Hypertension |
2.9% |
|
| Secondary |
| Gastrooesophageal Reflux Disease |
17.0% |
| Product Used For Unknown Indication |
11.4% |
| Gastritis |
10.2% |
| Hypertension |
9.1% |
| Depression |
8.0% |
| Drug Dependence |
6.8% |
| Gastric Disorder |
5.7% |
| Gastric Polyps |
5.7% |
| Panic Disorder |
4.5% |
| Gastric Ulcer |
3.4% |
| Anticoagulant Therapy |
2.3% |
| Gastritis Prophylaxis |
2.3% |
| Hypothyroidism |
2.3% |
| Migraine |
2.3% |
| Prophylaxis |
2.3% |
| Vasodilation Procedure |
2.3% |
| Abdominal Pain Upper |
1.1% |
| Antacid Therapy |
1.1% |
| Anxiety |
1.1% |
| Cardiac Disorder |
1.1% |
|
| Petechiae |
14.3% |
| Premature Baby |
14.3% |
| Somnolence |
14.3% |
| Venous Occlusion |
14.3% |
| Helicobacter Infection |
7.1% |
| Myalgia |
7.1% |
| Premature Separation Of Placenta |
7.1% |
| Rheumatoid Factor Increased |
7.1% |
| Urinary Incontinence |
7.1% |
| Weight Decreased |
7.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.4% |
| Crohn's Disease |
18.9% |
| Rheumatoid Arthritis |
13.8% |
| Gastrooesophageal Reflux Disease |
4.7% |
| Hypertension |
4.5% |
| Premedication |
3.3% |
| Hepatitis C |
2.8% |
| Adverse Event |
2.7% |
| Diabetes Mellitus |
2.7% |
| Pain |
2.5% |
| Ankylosing Spondylitis |
2.2% |
| Vitamin Supplementation |
2.2% |
| Osteoporosis |
2.0% |
| Colitis Ulcerative |
1.8% |
| Asthma |
1.7% |
| Psoriatic Arthropathy |
1.5% |
| Blood Cholesterol Increased |
1.3% |
| Sleep Disorder |
1.2% |
| Depression |
1.0% |
| Insomnia |
1.0% |
|
| Weight Decreased |
15.8% |
| Vomiting |
12.3% |
| Headache |
5.3% |
| Joint Swelling |
5.3% |
| Nephrolithiasis |
5.3% |
| Neuroleptic Malignant Syndrome |
5.3% |
| Vision Blurred |
5.3% |
| Anaemia |
3.5% |
| Arthritis |
3.5% |
| Cholelithiasis |
3.5% |
| Death |
3.5% |
| Drug Ineffective |
3.5% |
| Hypoaesthesia |
3.5% |
| Hypotension |
3.5% |
| Inappropriate Schedule Of Drug Administration |
3.5% |
| Infusion Related Reaction |
3.5% |
| Pain |
3.5% |
| Pituitary-dependent Cushing's Syndrome |
3.5% |
| Pneumonia |
3.5% |
| Pollakiuria |
3.5% |
|
| Interacting |
| Blood Thyroid Stimulating Hormone Increased |
33.3% |
| Dysphonia |
33.3% |
| Gastrooesophageal Reflux Disease |
33.3% |
|
|
